Get it on Google Play

Nastech (NSTK) Provides Update on Parathyroid Hormone, P&G Amends Contract

December 4, 2006 4:11 PM EST Send to a Friend
Nastech Pharmaceutical (Nasdaq: NSTK) provided an update on Parathyroid Hormone (PTH1-34) Nasal Spray, which is under development for the treatment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login